Kills 99% of known germs.
Autor: | Chris V. Prowse, William G. Murphy |
---|---|
Předmět: | |
Zdroj: | Transfusion; Aug2010, Vol. 50 Issue 8, p1636-1639, 4p, 1 Chart |
Abstrakt: | The article discusses the feasibility of pathogen reduction technology (PRT) in blood transfusion. The practical benefits of PRT, in terms of risk reduction, are most likely to be in reducing the incidence of bacterial and parasitic infections. Effectiveness of PRTs for nonlipid viruses, bacterial spores or prion diseases is less certain or absent. As mentioned, PRTs seem to be slowly gaining market acceptance and the problems of cost, toxicity, and loss of efficacy are under scrutiny. |
Databáze: | Complementary Index |
Externí odkaz: |